Cargando…

Botulinum a toxin treatment of hemifacial spasm and blepharospasm.

We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in the open trial and 6 patients in the double blind trial improved after the first injection of botulinum toxin. There was no i...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Y. C., Lim, J. K., Lee, D. K., Yi, S. D.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053713/
https://www.ncbi.nlm.nih.gov/pubmed/8305141
_version_ 1782199792333488128
author Park, Y. C.
Lim, J. K.
Lee, D. K.
Yi, S. D.
author_facet Park, Y. C.
Lim, J. K.
Lee, D. K.
Yi, S. D.
author_sort Park, Y. C.
collection PubMed
description We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in the open trial and 6 patients in the double blind trial improved after the first injection of botulinum toxin. There was no improvement with placebo. The peak effect ranged from one to 6 days after injection and mean peak effect was 3.6 days in blepharospasm, and 4 days in hemifacial spasm. Of 144 treatments, 98.6% had excellent results, (below grade I). The duration of beneficial effect ranged 11 to 40 weeks (mean 16.5 weeks) in hemifacial spasm and 9 to 30 weeks (mean 14.2 weeks) in blepharospasm. Complications were encountered in 63.4% in hemifacial spasm and 72.7% in blepharospasm. The common side effects were dry eyes, mouth droop, ptosis and lid edema in order of frequency. These side effects were mild and resolved spontaneously in 1 to 3 weeks. Botulinum A toxin therapy is effective and convenient, and the treatment of choice for patients with hemifacial spasm and blepharospasm.
format Text
id pubmed-3053713
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-30537132011-03-16 Botulinum a toxin treatment of hemifacial spasm and blepharospasm. Park, Y. C. Lim, J. K. Lee, D. K. Yi, S. D. J Korean Med Sci Research Article We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in the open trial and 6 patients in the double blind trial improved after the first injection of botulinum toxin. There was no improvement with placebo. The peak effect ranged from one to 6 days after injection and mean peak effect was 3.6 days in blepharospasm, and 4 days in hemifacial spasm. Of 144 treatments, 98.6% had excellent results, (below grade I). The duration of beneficial effect ranged 11 to 40 weeks (mean 16.5 weeks) in hemifacial spasm and 9 to 30 weeks (mean 14.2 weeks) in blepharospasm. Complications were encountered in 63.4% in hemifacial spasm and 72.7% in blepharospasm. The common side effects were dry eyes, mouth droop, ptosis and lid edema in order of frequency. These side effects were mild and resolved spontaneously in 1 to 3 weeks. Botulinum A toxin therapy is effective and convenient, and the treatment of choice for patients with hemifacial spasm and blepharospasm. Korean Academy of Medical Sciences 1993-10 /pmc/articles/PMC3053713/ /pubmed/8305141 Text en
spellingShingle Research Article
Park, Y. C.
Lim, J. K.
Lee, D. K.
Yi, S. D.
Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
title Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
title_full Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
title_fullStr Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
title_full_unstemmed Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
title_short Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
title_sort botulinum a toxin treatment of hemifacial spasm and blepharospasm.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053713/
https://www.ncbi.nlm.nih.gov/pubmed/8305141
work_keys_str_mv AT parkyc botulinumatoxintreatmentofhemifacialspasmandblepharospasm
AT limjk botulinumatoxintreatmentofhemifacialspasmandblepharospasm
AT leedk botulinumatoxintreatmentofhemifacialspasmandblepharospasm
AT yisd botulinumatoxintreatmentofhemifacialspasmandblepharospasm